The relationship between chronic obstructive pulmonary disease (COPD) and asthma patients who smoke and their likelihood of quitting is a complex issue. A recent multicenter trial from Turkey has shed some light on this topic by evaluating the impact of immediately linking these patients to a smoking cessation clinic. The results of the trial demonstrated
Health
Health officials in Missouri were puzzled when a hospitalized patient tested positive for bird flu despite having no known contact with dairy cows or other animals typically associated with the virus. This marks the 14th case of bird flu in the U.S. this year, following an initial detection in cows in March that later spread
The recent incident involving the No. 1-ranked tennis player, Jannik Sinner, and his failed drug tests due to the over-the-counter spray containing the banned anabolic steroid closetbol has raised questions about the accessibility and awareness of doping risks in sports. Sinner’s clearance last month after testing positive for closetbol has shed light on the loopholes
Respiratory syncytial virus (RSV) vaccination has been a topic of interest among researchers, especially in older adults. A recent study conducted from October 2023 to March 2024 indicated a promising outcome in terms of reducing the risk of hospitalization due to RSV among adults aged 60 and over. The findings of the study, led by
In a recent study conducted in Spain, researchers found that patients with inflammatory arthritis experienced better treatment retention rates with biosimilar versions of etanercept and adalimumab compared to the originator products. The study, led by María Paz Martínez-Vidal, MD, PhD, from Hospital Universitario San Juan de Alicante, revealed significant differences in discontinuation rates between biosimilars
The REC-CAGEFREE I trial recently conducted in China compared the outcomes of drug-coated balloon (DCB) angioplasty versus stenting as the initial strategy for de novo coronary artery stenoses. The results of the trial, presented at the European Society of Cardiology (ESC) meeting and published in The Lancet, revealed that DCB with rescue use of drug-eluting
Atrial fibrillation (Afib) and stable coronary artery disease (CAD) are two common conditions that often require antithrombotic therapy for management. A recent trial, EPIC-CAD, has shed light on the benefits of edoxaban (Savaysa) monotherapy compared to dual antithrombotic therapy in these patients. The study found that edoxaban monotherapy significantly improved net outcomes by reducing bleeding
In a recent randomized clinical trial, the practice of keeping potassium levels high after cardiac surgery to prevent post-surgical atrial fibrillation (Afib) has been called into question. The trial showed that supplementing potassium at a tight threshold of 4.5 mEq/L did not result in a significant reduction in new-onset Afib after coronary artery bypass surgery.
Research findings have revealed a significant breakthrough in Alzheimer’s disease research related to the APOE4 gene. A working group of senior investigators, led by the Alzheimer’s Disease Sequencing Project (ADSP), has come to a consensus that the APOE4 gene is definitively toxic, challenging previous beliefs in the field. This revelation not only paves the way
The landscape of tobacco retail is shifting, with new regulations set to have a significant impact on how tobacco products are sold. The FDA has issued a final rule that raises the minimum age for certain restrictions on tobacco product sales, in accordance with the Further Consolidated Appropriations Act signed in December 2019. One of